Works matching AU Kanes, Stephen J.

Results: 16

Investigación de los circuitos de atención visual en la esquizofrenia mediante resonancia magnética funcional bajo un paradigma de rareza.

Published in:

American Journal of Psychiatry - Edición Española, 2007, v. 10, n. 6, p. 345

By:

Gur, Raquel E.;
Turetsky, Bruce I.;
Loughead, James;
Snyder, Wendy;
Kohler, Christian;
Elliott, Mark;
Pratiwadi, Ramapriyan;
Ragland, J. Daniel;
Bilker, Warren B.;
Siegel, Steven J.;
Kanes, Stephen J.;
Arnold, Steven E.;
Gur, Ruben C.

Publication type:

Article

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.

Published in:

2021

By:

Deligiannidis, Kristina M.;
Meltzer-Brody, Samantha;
Gunduz-Bruce, Handan;
Doherty, James;
Jonas, Jeffrey;
Li, Sigui;
Sankoh, Abdul J.;
Silber, Christopher;
Campbell, Andrew D.;
Werneburg, Brian;
Kanes, Stephen J.;
Lasser, Robert

Publication type:

journal article

Achieving clinical response in postpartum depression leads to improvement in health-related quality of life.

Published in:

Current Medical Research & Opinion, 2021, v. 37, n. 7, p. 1221, doi. 10.1080/03007995.2021.1902295

By:

Gerbasi, Margaret E.;
Kosinski, Mark;
Meltzer-Brody, Samantha;
Acaster, Sarah;
Fridman, Moshe;
Huang, Ming-Yi;
Bonthapally, Vijayveer;
Hodgkins, Paul;
Kanes, Stephen J.;
Eldar-Lissai, Adi

Publication type:

Article

Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders.

Published in:

Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 811, doi. 10.2147/NDT.S402831

By:

Kanes, Stephen J;
Dennie, Lara;
Perera, Philip

Publication type:

Article

SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.

Published in:

2020

By:

Hoffmann, Ethan;
Nomikos, George G.;
Kaul, Inder;
Raines, Shane;
Wald, Jeff;
Bullock, Amy;
Sankoh, Abdul J.;
Doherty, James;
Kanes, Stephen J.;
Colquhoun, Helen

Publication type:

journal article

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making.

Published in:

Journal of Women's Health (15409996), 2021, v. 30, n. 3, p. 385, doi. 10.1089/jwh.2020.8483

By:

Gerbasi, Margaret E.;
Meltzer-Brody, Samantha;
Acaster, Sarah;
Fridman, Moshe;
Bonthapally, Vijayveer;
Hodgkins, Paul;
Kanes, Stephen J.;
Eldar-Lissai, Adi

Publication type:

Article

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.

Published in:

Archives of Women's Mental Health, 2020, v. 23, n. 5, p. 727, doi. 10.1007/s00737-020-01042-y

By:

Gerbasi, Margaret E.;
Eldar-Lissai, Adi;
Acaster, Sarah;
Fridman, Moshe;
Bonthapally, Vijayveer;
Hodgkins, Paul;
Kanes, Stephen J.;
Meltzer-Brody, Samantha

Publication type:

Article

Brexanolone as adjunctive therapy in super-refractory status epilepticus.

Published in:

2017

By:

Rosenthal, Eric S.;
Claassen, Jan;
Wainwright, Mark S.;
Husain, Aatif M.;
Vaitkevicius, Henrikas;
Raines, Shane;
Hoffmann, Ethan;
Colquhoun, Helen;
Doherty, James J.;
Kanes, Stephen J.

Publication type:

journal article

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 1, p. 1, doi. 10.1002/hup.2806

By:

Bullock, Amy;
Gunduz‐Bruce, Handan;
Zammit, Gary K.;
Qin, Min;
Li, Haihong;
Sankoh, Abdul J.;
Silber, Christopher;
Kanes, Stephen J.;
Jonas, Jeffrey;
Doherty, James

Publication type:

Article

Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 2, p. n/a, doi. 10.1002/hup.2576

By:

Kanes, Stephen J.;
Colquhoun, Helen;
Doherty, James;
Raines, Shane;
Hoffmann, Ethan;
Rubinow, David R.;
Meltzer‐Brody, Samantha

Publication type:

Article

Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP.

Published in:

Neuropsychopharmacology, 2007, v. 32, n. 3, p. 577, doi. 10.1038/sj.npp.1301099

By:

Kelly, Michele P.;
Isiegas, Carolina;
York-Fong Cheung;
Tokarczyk, Jan;
Xioaju Yang;
Esposito, Michael F.;
Rapoport, David A.;
Fabian, Sara A.;
Siegel, Steven J.;
Wand, Gary;
Houslay, Miles D.;
Kanes, Stephen J.;
Abel, Ted

Publication type:

Article

Corticosterone Modulates Auditory Gating in Mouse.

Published in:

Neuropsychopharmacology, 2006, v. 31, n. 5, p. 897, doi. 10.1038/sj.npp.1300879

By:

Maxwell, Christina R.;
Ehrlichman, Richard S.;
Liang, Yuling;
Gettes, David R.;
Evans, Dwight L.;
Kanes, Stephen J.;
Abel, Ted;
Karp, Jonathan;
Siegel, Steven J

Publication type:

Article

Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 5, p. 960, doi. 10.1038/sj.npp.1300385

By:

Irani, Farzin;
Dankert, Mary;
Brensinger, Colleen;
Bilker, Warren B.;
Nair, Sudha R.;
Kohler, Christian G.;
Kanes, Stephen J.;
Turetsky, Bruce I.;
Moberg, Paul J.;
Ragland, John D.;
Gur, Ruben C.;
Gur, Raquel E.;
Siegel, Steven J.

Publication type:

Article

Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse NI Auditory Evoked Potential.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 4, p. 739, doi. 10.1038/sj.npp.1300376

By:

Maxwell, Christina R.;
Yuling Liang, Christina R.;
Weightman, Bryanne D.;
Kanes, Stephen J.;
Abel, Ted;
Gur, Raquel E.;
Turetsky, Bruce I.;
Bilker, Warren B.;
Lenox, Robert H.;
Siegel, Steven J.

Publication type:

Article

Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of G5α.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 494, doi. 10.1038/sj.npp.1300309

By:

Gould, Thomas J.;
Bizily, Scott P.;
Tokarczyk, Jan;
Kelly, Michele P.;
Siegel, Steven J.;
Kanes, Stephen J.;
Abel, Ted

Publication type:

Article

Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.

Published in:

Psychopharmacology, 2007, v. 190, n. 2, p. 201, doi. 10.1007/s00213-006-0616-8

By:

Metzger, Kayla L.;
Shoemaker, Jody M.;
Kahn, Jonathan B.;
Maxwell, Christina R.;
Yuling Liang;
Tokarczyk, Jan;
Kanes, Stephen J.;
Hans, Meredith;
Lowman, Anthony M.;
Dan, Nily;
Winey, Karen I.;
Swerdlow, Neal R.;
Siegel, Steven J.

Publication type:

Article

Works matching AU Kanes, Stephen J.

Investigación de los circuitos de atención visual en la esquizofrenia mediante resonancia magnética funcional bajo un paradigma de rareza.

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.

Achieving clinical response in postpartum depression leads to improvement in health-related quality of life.

Targeting the Arginine Vasopressin V<sub>1b</sub> Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders.

SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making.

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.

Brexanolone as adjunctive therapy in super-refractory status epilepticus.

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults.

Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.

Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP.

Corticosterone Modulates Auditory Gating in Mouse.

Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine.

Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse NI Auditory Evoked Potential.

Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of G<sub>5</sub>α.

Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.